bellavista 1000 Ventilator, Catalogue Number 301.100.030; Continuous Use Ventilator
FDA Device Recall #Z-1966-2023 — Class II — May 5, 2023
Recall Summary
| Recall Number | Z-1966-2023 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 5, 2023 |
| Status | Completed |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Vyaire Medical |
| Location | Mettawa, IL |
| Product Type | Devices |
| Quantity | 910 units |
Product Description
bellavista 1000 Ventilator, Catalogue Number 301.100.030; Continuous Use Ventilator
Reason for Recall
Vyaire Medical identified two patient safety risks during the use of the bellavista 1000 and bellavista 1000e: 1. Under certain conditions of use, the touchscreen may become unresponsive and the device application stops responding (APP Hang). When this occurs, if the user continues to interact with the touchscreen, a message will appear that states DeviceSoftware.Application is not responding or a decommission screen will appear on the user interface. The ventilator will issue both an audible and visual alarm. Ventilation continues without interruption with the settings applied prior to the APP Hang error. 2. The potential for a use error has been identified if the operator applies the proposed settings without confirming the settings are suitable for the patient.
Distribution Pattern
US Nationwide Distribution
Lot / Code Information
UDI/DI: 10190752197664 and 07640149381115, ALL serial numbers with Software Version 6.1.0.2 and 6.1.1
Other Recalls from Vyaire Medical
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1697-2025 | Class I | Brand Name: AirLife Product Name: AirLife Infa... | Apr 10, 2025 |
| Z-1698-2025 | Class I | Brand Name: AirLife Product Name: AirLife Infa... | Apr 10, 2025 |
| Z-1061-2024 | Class I | AirLife Adult Manual Resuscitator, 40" (1.0m) O... | Jan 10, 2024 |
| Z-1065-2024 | Class I | AirLife Adult Manual Resuscitator, 40" (1.0m) O... | Jan 10, 2024 |
| Z-1064-2024 | Class I | AirLife Adult Manual Resuscitator, Variable Vol... | Jan 10, 2024 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.